Arax Advisory Partners
Position in DMII — Drugs Made In America Acquisition II Corp.
CIK 1586767
DENVER, CO
Position in DMII
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$663,859
New position
Shares Held
131,980
first reported quarter
Ownership
0.207%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#64
of 76 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Shell Companies
Financial Services · as of Jun 30, 2026Arax Advisory Partners holds $10,822,765 across 68 Shell Companies names. DMII ranks #5 (6.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CEPF |
Cantor Equity Partners IV, Inc.
|
109,800 | $1,141,920 | |
| 2 | MBVI |
M3-Brigade Acquisition VI Corp.
|
148,000 | $1,124,430 | |
| 3 | KOYN |
CSLM Digital Asset Acquisition Corp III, Ltd
|
147,587 | $1,011,972 | |
| 4 | LAFA |
LaFayette Acquisition Corp.
|
187,520 | $945,100 | |
| 5 | DMII |
Drugs Made In America Acquisition II Corp.
This page
|
131,980 | $663,859 | |
| 6 | BDCI |
BTC Development Corp.
|
72,935 | $587,564 | |
| 7 | MKLY |
McKinley Acquisition Corp
|
111,947 | $574,662 | |
| 8 | BLRK |
Bluerock Acquisition Corp.
|
75,728 | $566,824 |
All Filings in DMII
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $663,859 | 65,990 | Shares | Sole | 2026-08-10 | |
| No filing history on record for this holder in this stock. | ||||||